Claims for Patent: 7,868,044

Summary for Patent: 7,868,044

Title:	Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid
Abstract:	Dermatological disorders having an inflammatory or proliferative component, notably common acne, are treated with topically applicable pharmaceutical compositions containing about 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously formulated into topically applicable gels, preferably aqueous gels, creams, lotions or solutions.
Inventor(s):	Graeber; Michael (Lawrenceville, NJ), Czernielewski; Janusz (Biot, FR)
Assignee:	Galderma Research & Development (Biot, FR)
Application Number:	12/772,861
Patent Claims:	1. A method for treating acne afflicting the skin of an individual in need of such treatment, comprising topically administering to said individual a topically applicable pharmaceutical aqueous gel composition consisting essentially of an anti-acne effective amount of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) of 0.3% by weight thereof, formulated into a topically applicable, pharmaceutically acceptable aqueous gel medium therefor, wherein adapalene is the only active anti-acne ingredient in the composition and wherein said aqueous gel medium comprises at least one ingredient selected from the group consisting of carbomers, polymeric emulsifying agents, polysaccharidic biopolymers, gums, alginates, modified celluloses, starch derived products, mix of polysorbate 80 and isohexadecane and acrylamide/sodium acryloyldimethyltaurate, and mixtures thereof. 2. The method as defined by claim 1, wherein the individual is afflicted with common acne. 3. The method as defined by claim 1, wherein said aqueous gel medium comprises: Carbomer, Disodium edetate, Methyl paraben, Poloxamer 124, Propylene glycol, Sodium hydroxide, and Purified water. 4. The method as defined by claim 1, wherein said topically applicable pharmaceutical aqueous gel composition consists essentially of: TABLE-US-00013 Adapalene 3 mg Carbomer 940 11 mg Disodium edetate 1 mg Methyl paraben 2 mg Poloxamer 124 2 mg Propylene glycol 40 mg Sodium hydroxide: amount required to obtain a pH 5.0 +/- 0.3 and Purified water q.s. 1 g. 5. The method as defined by claim 1, wherein said aqueous gel medium comprises: Xanthan gum, Hydroxypropylethylcellulose, Disodium edetate, Methyl paraben, Phenoxyethanol, Poloxamer 124, Propylene glycol, and Purified water. 6. The method as defined by claim 1, wherein said topically applicable pharmaceutical aqueous gel composition consists essentially of: TABLE-US-00014 Adapalene 3 mg Xanthan gum 8 mg Hydroxypropylethylcellulose 10 mg Disodium edetate 1 mg Methyl paraben 2 mg Phenoxyethanol 10 mg Poloxamer 124 2 mg Propylene glycol 40 mg Purified water q.s. 1 g. 7. A method for treating acne afflicting the skin of an individual in need of such treatment, comprising topically administering to said individual a topically applicable pharmaceutical aqueous cream gel composition consisting essentially of an anti-acne effective amount of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) of 0.3% by weight thereof, formulated into a topically applicable, pharmaceutically acceptable aqueous cream gel medium therefor, wherein adapalene is the only active anti-acne ingredient in the composition. 8. The method as defined by claim 7, wherein the individual is afflicted with common acne. 9. The method as defined by claim 7, wherein said aqueous cream gel medium comprises: Simulgel 600 PHA, Cetearyl isononanoate, Disodium edetate, Methyl paraben, Poloxamer 124, Propylene glycol, and Purified water. 10. The method as defined by claim 7, wherein said topically applicable pharmaceutical aqueous cream gel composition consists essentially of: TABLE-US-00015 Adapalene 3 mg Simulgel 600 PHA 20 mg Cetearyl isononanoate 100 mg Disodium edetate 1 mg Methyl paraben 2 mg Poloxamer 124 2 mg Propylene glycol 40 mg Purified water q.s. 1 g. 11. The method as defined by claim 7, wherein said aqueous cream gel medium comprises: Pemulen TR1, Mineral Oil, Disodium edetate, Methyl paraben, Propyl paraben, Poloxamer 124, Propylene glycol, Sodium hydroxide: amount required to obtain a pH 5.0+/-0.3, and Purified water. 12. The method as defined by claim 7, wherein said topically applicable pharmaceutical aqueous cream gel composition consists essentially of: TABLE-US-00016 Adapalene 3 mg Pemulen TR1 5 mg Mineral oil 120 mg Disodium edetate 1 mg Methyl paraben 2 mg Propyl paraben 1 mg Poloxamer 124 2 mg Propylene glycol 40 mg Sodium hydroxide: amount required to obtain a pH 5.0 +/- 0.3 Purified water q.s. 1 g. 13. A method for treating acne afflicting the skin of an individual in need of such treatment, comprising topically administering to said individual a topically applicable pharmaceutical cream composition consisting essentially of an anti-acne effective amount of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) of 0.3% by weight thereof, formulated into a topically applicable, pharmaceutically acceptable cream medium therefor, wherein adapalene is the only active anti-acne ingredient in the composition. 14. The method as defined by claim 13, wherein the individual is afflicted with common acne. 15. The method as defined by claim 13, wherein said cream medium comprises at least one ingredient selected from the group consisting of silicone oils, siliconed oily substances, siliconed fatty substances, non-siliconed fatty substances, vegetable oils, mineral oils, animal oils and synthetic oils, and mixtures thereof. 16. The method as defined by claim 15, wherein said cream medium comprises at least one ingredient selected from the group consisting of perhydrosqualene, cyclomethicone, PEG-20 methyl glucose sequistearate, methyl glucose sequistearate, and mixtures thereof. 17. The method as defined by claim 13, wherein said cream medium comprises: Carbomer 934 (BF Goodrich Carbopol 974), Disodium edetate, PEG 20 methyl glucose sesquistearate, Methyl glucose sesquistearate, Glycerol, Methyl paraben, Cyclomethicone, Perhydrosqualene, Phenoxyethanol, Propyl paraben, Sodium hydroxide quantity required for pH 6.5+/-0.3, and Purified water. 18. The method as defined by claim 13, wherein said topically applicable pharmaceutical cream composition consists essentially of: TABLE-US-00017 Adapalene 3 mg Carbomer 934 (BF Goodrich Carbopol 974) 4.5 mg Disodium edetate 1 mg PEG 20 methyl glucose sesquistearate 35 mg Methyl glucose sesquistearate 5 mg Glycerol 30 mg Methyl paraben 2 mg Cyclomethicone 130 mg Perhydrosqualene 60 mg Phenoxyethanol 5 mg Propyl paraben 1 mg Sodium hydroxide quantity required for pH 6.5 +/- 0.3 Purified water q.s. 1 g. 19. A method for treating acne afflicting the skin of an individual in need of such treatment, comprising topically administering to said individual a topically applicable pharmaceutical aqueous lotion composition consisting essentially of an anti-acne effective amount of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) of 0.3% by weight thereof, formulated into a topically applicable, pharmaceutically acceptable aqueous lotion medium therefor, wherein adapalene is the only active anti-acne ingredient in the composition. 20. The method as defined by claim 19, wherein the individual is afflicted with common acne. 21. The method as defined by claim 19, wherein said aqueous lotion medium comprises at least one ingredient selected from the group consisting of humectant agent, pro-penetrant agent, propylene glycol, PEG400, mineral oils, lipophilic substances, caprilic/capric triglycerides, emulsifying agent, and mixtures thereof. 22. The method as defined by claim 19, wherein said aqueous lotion medium comprises at least one ingredient selected from the group consisting of propylene glycol, glycerine, sorbitol, polyethylene glycol, mineral oils, perhydrosqualene, caprilic/capric triglycerides, PEG-20 methyl glucose sequistearate, methyl glucose sequistearate, and mixtures thereof. 23. The method as defined by claim 19, wherein said aqueous lotion medium comprises: Methyl paraben, Simulgel 600 PHA, Steareth 21, Glyceryl and PEG 100 stearate, Disodium edetate, Propyl paraben, Perhydrosqualene, Cetearyl isononanoate, Sodium Hydroxide 10% m/m, and Purified water. 24. The method as defined by claim 19, wherein said topically applicable pharmaceutical aqueous lotion composition consists essentially of: TABLE-US-00018 (% w/w) Adapalene 0.30 Methyl paraben 0.15 Simulgel 600 PHA 1.00 Steareth 21 3.00 Glyceryl and PEG 100 stearate 3.00 Disodium edetate 0.10 Propyl paraben 0.05 Perhydrosqualene 5.00 Cetearyl isononanoate 5.00 Sodium Hydroxide 10% m/m q.s. pH 5.5 .+-. 0.5 Purified water q.s. 100. 25. The method as defined by claim 19, wherein said aqueous lotion medium comprises: Disodium EDTA, Methyl paraben, Glycerine, Carbopol 981 NF, Propyl paraben, Ceteareth 20, Stearyl alcohol, Caprilic/capric triglycerides, Glyceryl and PEG 100 stearate, Cyclomethicone 5, Poloxamer 124, Propylene glycol, Simulgel 600 PHA, Solution aq. NaOH 10%, and Purified water. 26. The method as defined by claim 19, wherein said topically applicable pharmaceutical aqueous lotion composition consists essentially of: TABLE-US-00019 (% w/w) Disodium EDTA 0.1 Methyl paraben 0.2 Glycerine 7.0 Carbopol 981 NF 0.15 Propyl paraben 0.1 Ceteareth 20 3.0 Stearyl alcohol 2.0 Caprilic/capric triglycerides 7 Glyceryl and PEG 100 stearate 3.0 Cyclomethicone 5 6 Poloxamer 124 0.2 Propylene glycol 4.0 Adapalene 0.3 Simulgel 600 PHA 1.0 Solution aq. NaOH 10% 0.4 Purified water q.s. 100. 27. The method as defined by claim 19, wherein said aqueous lotion medium comprises: EDTA disodium, Methyl paraben, Carbopol 980 NF, Carbopol 981 NF, Gylcerine, Phenoxyethanol, Propyl paraben, Methyl glucose sesquistearate, PEG 20 methyl glucose sesquistearate, Caprilic/capric triglycerides, Dimethicone 20 cst, Poloxamer 124, Propylene glycol, Sodium Hydroxide 10% m/m, and Purified water. 28. The method as defined by claim 19, wherein said topically applicable pharmaceutical aqueous lotion composition consists essentially of: TABLE-US-00020 (% w/w) Disodium EDTA 0.1 Methyl paraben 0.2 Glycerine 7.0 Carbopol 981 NF 0.15 Propyl paraben 0.1 Ceteareth 20 3.0 Stearyl alcohol 2.0 Caprilic/capric triglycerides 7 Glyceryl and PEG 100 stearate 3.0 Cyclomethicone 5 6 Poloxamer 124 0.2 Propylene glycol 4.0 Adapalene 0.3 Simulgel 600 PHA 1.0 Solution aq. NaOH 10% 0.4 Purified water q.s. 100. 29. A method for treating acne afflicting the skin of an individual in need of such treatment, comprising topically administering to said individual a topically applicable pharmaceutical spray solution composition consisting essentially of an anti-acne effective amount of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) of 0.3% by weight thereof, formulated into a topically applicable, pharmaceutically acceptable spray solution medium therefor, said spray solution medium comprising caprilic/capric triglycerides, wherein adapalene is the only active anti-acne ingredient in the composition. 30. The method as defined by claim 29, wherein the individual is afflicted with common acne. 31. The method as defined by claim 29, wherein said spray solution medium further comprises at least one ingredient selected from the group consisting of humectant agent, pro-penetrant agent, propylene glycol, polyethylene glycol, PEG400, a lipophilic substance, siliconed fatty substances, non-siliconed fatty substances, and mixtures thereof. 32. The method as defined by claim 29, wherein said spray solution medium comprises: Caprilic/capric triglycerides, N-methylpyrrolidone, and Ethanol. 33. The method as defined by claim 29, wherein said topically applicable pharmaceutical spray solution composition consists essentially of: TABLE-US-00021 (% w/w) Adapalene 0.3 Caprilic/capric triglycerides 50 N-methyl pyrrolidone 3 Ethanol q.s. 100. 34. The method as defined by claim 1, wherein said aqueous gel medium comprises at least one inert additive selected from the group consisting of: wetting agents; flavor enhancers; preservatives; stabilizers; moisture regulators; pH regulators; osmotic pressure modifiers; emulsifiers; UV-A and UV-B screening agents; Antioxidants; and combinations thereof. 35. The method as defined by claim 7, wherein said aqueous cream gel medium comprises at least one inert additive selected from the group consisting of: wetting agents; flavor enhancers; preservatives; stabilizers; moisture regulators; pH regulators; osmotic pressure modifiers; emulsifiers; UV-A and UV-B screening agents; Antioxidants; and combinations thereof. 36. The method as defined by claim 13, wherein said cream medium comprises at least one inert additive selected from the group consisting of: wetting agents; flavor enhancers; preservatives; stabilizers; moisture regulators; pH regulators; osmotic pressure modifiers; emulsifiers; UV-A and UV-B screening agents; Antioxidants; and combinations thereof. 37. The method as defined by claim 19, wherein said aqueous lotion medium comprises at least one inert additive selected from the group consisting of: wetting agents; flavor enhancers; preservatives; stabilizers; moisture regulators; pH regulators; osmotic pressure modifiers; emulsifiers; UV-A and UV-B screening agents; Antioxidants; and combinations thereof. 38. The method as defined by claim 29, wherein said spray solution medium comprises at least one inert additive selected from the group consisting of: wetting agents; flavor enhancers; preservatives; stabilizers; moisture regulators; pH regulators; osmotic pressure modifiers; emulsifiers; UV-A and UV-B screening agents; Antioxidants; and combinations thereof. 39. The method as defined by claim 19, wherein said topically applicable pharmaceutical aqueous lotion composition consists essentially of: TABLE-US-00022 (% w/w) EDTA disodium 0.1 Methyl paraben 0.2 Carbopol 980 NF 0.15 Carbopol 981 NF 0.3 Gylcerine 3.0 Phenoxyethanol 1.0 Propyl paraben 0.2 Methyl glucose sesquistearate 1.0 PEG 20 methyl glucose sesquistearate 5.0 Caprilic/capric triglycerides 6.0 Dimethicone 20 cst 1.0 Poloxamer 124 0.2 Propylene glycol 4 Adapalene 0.3 Sodium Hydroxide 10% m/m 0.8 Purified water q.s. 100. 40. The method as defined by claim 1, wherein said aqueous gel medium comprises at least one carbomer. 41. The method as defined by claim 1, wherein said aqueous gel medium comprises carbomer 940.